Comparison of transcoronary ablation of septal hypertrophy (TASH) and Mavacamten treatment in patients with obstructive hypertrophic cardiomyopathy: a single-center study
11 May 2026 (13:30 - 14:15)
Organised by: 

Abstract
Slides
About the speaker

University Hospital Heidelberg, Heidelberg (Germany)
6 More presentations in this session
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Doctor F. Banfi-Bacsardi (Budapest, HU)
Access the full session
The Event
Heart Failure 2026
11 May 2026
13:30 CET
